mrjСовременная ревматологияModern Rheumatology Journal1996-70122310-158XIMA-PRESS, LLC10.14412/1996-7012-2022-6-98-105mrj-1378Research ArticleОБЗОРЫREVIEWSОстеоартрит суставов кистей: распространенность, факторы риска, фенотипы, диагностика, лечениеOsteoarthritis of hand joints: prevalence, risk factors, phenotypes, diagnosis, treatmenthttps://orcid.org/0000-0001-7017-0898АлексееваЛ. И.AlekseevaL. I

Алексеева Людмила Ивановна - кафедра ревматологии РМАНПО МЗ РФ.

115522, Москва, Каширское шоссе, 34А; 125993, Москва, ул. Баррикадная, 2/1, стр. 1

Lyudmila I. Alekseeva - Department of Rheumatology Russian Medical Academy of Continuing Professional Education, Ministry of Health of Russia.

34A, Kashirskoe Shosse, Moscow 115522; 22/1, Barrikadnaya Street, Build. 1, Moscow 125993

dr.alekseeva@gmail.comhttps://orcid.org/0000-0003-2048-5183ШараповаЕ. П.SharapovaE. P.

115522, Москва, Каширское шоссе, 34А

34A, Kashirskoe Shosse, Moscow 115522

https://orcid.org/0000-0002-6068-3080ЛилаА. М.LilaA. M.

Кафедра ревматологии РМАНПО МЗ РФ.

115522, Москва, Каширское шоссе, 34А; 125993, Москва, ул. Баррикадная, 2/1, стр. 1

Department of Rheumatology Russian Medical Academy of Continuing Professional Education, Ministry of Health of Russia.

34A, Kashirskoe Shosse, Moscow 115522; 22/1, Barrikadnaya Street, Build. 1, Moscow 125993

Научно-исследовательский институт ревматологии им. В.А. Насоновой; Российская медицинская академия непрерывного профессионального образования Минздрава РоссииРоссияV.A. Nasonova Research Institute of Rheumatology, Moscow; Russian Medical Academy of Continuing Professional Education, Ministry of Health of RussiaRussian FederationНаучно-исследовательский институт ревматологии им. В.А. НасоновойРоссияV.A. Nasonova Research Institute of RheumatologyRussian Federation20221812202216698105Copyright © Алексеева Л.И., Шарапова Е.П., Лила А.М., 20222022Алексеева Л.И., Шарапова Е.П., Лила А.М.Alekseeva L.I., Sharapova E.P., Lila A.M.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://mrj.ima-press.net/mrj/article/view/1378

Остеоартрит — самое распространенное ревматическое заболевание, сопровождающееся постоянной болью и нарушением функции суставов, прогрессирование которого приводит к ухудшению качества жизни и нередко к инвалидизации пациентов. В статье представлены распространенность, предикторы развития и прогрессирования остеоартрита суставов кистей (ОАК). Приведены клиническая классификация ОАК, клиническая картина заболевания в зависимости от локализации процесса, топические особенности вовлечения суставов кистей при разных вариантах ОАК. Описаны клинические и лабораторно-инструментальные методы диагностики заболевания, классификационные и диагностические критерии, большое внимание уделено современным принципам терапии ОАК в соответствии с российскими клиническими рекомендациями, а также рекомендациями EULAR и ACR.

Osteoarthritis is the most common rheumatic disease, accompanied by constant pain and dysfunction of the joints, the progression of which leads to a deterioration in the quality of life and often to disability of patients. The article presents the prevalence, predictors of development and progression of osteoarthritis of the hand joints (OHJ). Clinical classification of OHJ, clinical picture depending on the localization of the process, topical features of involvement of the hand joints in different types of OHJ are given. Clinical, laboratory and instrumental methods for diagnosing of the disease, classification and diagnostic criteria are described, much attention is paid to modern principles of OHJ therapy in accordance with Russian clinical guidelines, as well as EULAR and ACR recommendations.

остеоартрит суставов кистейфенотипыэпидемиологияклассификацияфакторы рискаклинические проявлениядиагностикалечениеosteoarthritis of the hand jointsphenotypesepidemiologyclassificationrisk factorsclinical manifestationsdiagnosticstreatmentИсследование выполнено в рамках Государственного задания по теме № N1021051403074-2.The investigation has been conducted within scientific topic №N1021051403074-2ReferencesЛила АМ, Лила ВА. Социальная значимость и экономические последствия ревматических заболеваний. Гигиена и санитария. 2017;(4):387-92.Lila AM, Lila VA. Social significance and economic consequences of rheumatic diseases. Gigiena i sanitariya. 2017;(4):387-92. (In Russ.).Sangha O. Epidemiology of rheumatic disease. Rheumatology (Oxford). 2000 Dec;39 Suppl 2:3-12. doi: 10.1093/rheumatology/39.suppl_2.3.Sangha O. Epidemiology of rheumatic disease. Rheumatology (Oxford). 2000 Dec;39 Suppl 2:3-12. doi: 10.1093/rheumatology/39.suppl_2.3.Zhang W, Doherty M, Leeb BF, et al. EULAR evidence-based recommendations for the diagnosis of hand osteoarthritis: report of a task force of ESCISIT. Ann Rheum Dis. 2009 Jan;68(1):8-17. doi: 10.1136/ard.2007.084772. Epub 2008 Feb 4.Zhang W, Doherty M, Leeb BF, et al. EULAR evidence-based recommendations for the diagnosis of hand osteoarthritis: report of a task force of ESCISIT. Ann Rheum Dis. 2009 Jan;68(1):8-17. doi: 10.1136/ard.2007.084772. Epub 2008 Feb 4.Алексеева ЛИ, Таскина ЕА, Кашеварова НГ. Остеоартрит: эпидемиология, классификация, факторы риска и прогрессирования, клиника, диагностика, лечение. Современная ревматология. 2019;13(2):9-21. doi: 10.14412/1996-7012-2019-2-9-21Alekseeva LI, Taskina EA, Kashevarova NG. Osteoarthritis: epidemiology, classification, risk factors, and progression, clinical presentation, diagnosis, and treatment. Sovremennaya revmatologiya = Modern Rheumatology Journal. 2019;13(2):9-21. (In Russ.). doi: 10.14412/1996-7012-2019-2-9-21Kloppenburg M, Kwok WY. Hand osteoarthritis — a heterogeneous disorder. Nat Rev Rheumatol. 2011 Nov 22;8(1):22-31. doi: 10.1038/nrrheum.2011.170.Kloppenburg M, Kwok WY. Hand osteoarthritis — a heterogeneous disorder. Nat Rev Rheumatol. 2011 Nov 22;8(1):22-31. doi: 10.1038/nrrheum.2011.170.Zhang Y, Niu J, Kelly-Hayes M, et al. Prevalence of symptomatic hand osteoarthritis and its impact on functional status among elderly: the Framingham Study. Am J Epidemiol. 2002 Dec 1;156(11):1021-7. doi: 10.1093/ aje/kwf141.Zhang Y, Niu J, Kelly-Hayes M, et al. Prevalence of symptomatic hand osteoarthritis and its impact on functional status among elderly: the Framingham Study. Am J Epidemiol. 2002 Dec 1;156(11):1021-7. doi: 10.1093/ aje/kwf141.Wright GD, Regan M, Deighton CM, et al. Evidence for genetic anticipation in nodal osteoarthritis. Ann Rheum Dis. 1998 Sep;57(9): 524-6. doi: 10.1136/ard.57.9.524.Wright GD, Regan M, Deighton CM, et al. Evidence for genetic anticipation in nodal osteoarthritis. Ann Rheum Dis. 1998 Sep;57(9): 524-6. doi: 10.1136/ard.57.9.524.Штерн К. Основы генетики человека. Москва: Медицина; 1965. C.196.Shtern K. Osnovy genetiki cheloveka [Fundamentals of human genetics]. Moscow: Meditsina; 1965. P.196.Gazeley DJ, Yeturi S, Patel PJ, Rosenthal AK. Erosive osteoarthritis: A systematic analysis of definitions used in the literature. Semin Arthritis Rheum. 2017 Feb;46(4):395-403. doi: 10.1016/j.semarthrit.2016.08.013. Epub 2016 Aug 24.Gazeley DJ, Yeturi S, Patel PJ, Rosenthal AK. Erosive osteoarthritis: A systematic analysis of definitions used in the literature. Semin Arthritis Rheum. 2017 Feb;46(4):395-403. doi: 10.1016/j.semarthrit.2016.08.013. Epub 2016 Aug 24.Poletto E, Tinazzi I, Marchetta A, et al. Hand Erosive Osteoarthritis and Distal Inter-phalangeal Involvement in Psoriatic Arthritis: The Place of Conservative Therapy. J Clin Med. 2021 Jun 15;10(12):2630. doi: 10.3390/jcm10122630.Poletto E, Tinazzi I, Marchetta A, et al. Hand Erosive Osteoarthritis and Distal Inter-phalangeal Involvement in Psoriatic Arthritis: The Place of Conservative Therapy. J Clin Med. 2021 Jun 15;10(12):2630. doi: 10.3390/jcm10122630.Смирнов АВ. Атлас рентгенологической диагностики первичного остеоартроза. Москва: ИМА-ПРЕСС; 2010.Smirnov AV. Atlas rentgenologicheskoi diagnostiki pervichnogo osteoartroza [Atlas of radiological diagnostics of primary osteoarthritis]. Moscow: IMA-PRESS; 2010.Кудинский ДМ, Смирнов АВ, Алексеева ЛИ. Сравнение рентгенографии и магнитно-резонансной томографии при диагностике остеоартрита суставов кистей. Научно-практическая ревматология. 2019;57(1):91-9.Kudinsky DM, Smirnov AV, Alekseeva LI. Comparison of X-ray and magnetic resonance imaging in the diagnosis of osteoarthritis of the joints of the hands. Nauchno-prakticheskaya revmatologiya. 2019;57(1):91-9 (In Russ.).Altman R, Alarcn G, Appelrouth D, et al. The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hand. Arthritis Rheum. 1990 Nov;33(11):1601-10. doi: 10.1002/art.1780331101.Altman R, Alarcn G, Appelrouth D, et al. The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hand. Arthritis Rheum. 1990 Nov;33(11):1601-10. doi: 10.1002/art.1780331101.Zhang W, Doherty M, Leeb BF, et al. Review. EULAR evidence based recommendations for the management of hand osteoarthritis: report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis. 2007 Mar;66(3):377-88. doi: 10.1136/ard.2006.062091.Zhang W, Doherty M, Leeb BF, et al. Review. EULAR evidence based recommendations for the management of hand osteoarthritis: report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis. 2007 Mar;66(3):377-88. doi: 10.1136/ard.2006.062091.Kloppenburg M, Kroon FP, Blanco FJ, et al. 2018 update of the EULAR recommendations for the management of hand osteoarthritis. Ann Rheum Dis. 2019 Jan;78(1):16-24. doi: 10.1136/annrheumdis-2018-213826. Epub 2018 Aug 28.Kloppenburg M, Kroon FP, Blanco FJ, et al. 2018 update of the EULAR recommendations for the management of hand osteoarthritis. Ann Rheum Dis. 2019 Jan;78(1):16-24. doi: 10.1136/annrheumdis-2018-213826. Epub 2018 Aug 28.Bannuru RR, Osani MC, Vaysbrot EE, et al. OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis. Osteoarthritis Cartilage. 2019 Nov;27(11):1578-89. doi: 10.1016/j.joca.2019.06.011. Epub 2019 Jul 3.Bannuru RR, Osani MC, Vaysbrot EE, et al. OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis. Osteoarthritis Cartilage. 2019 Nov;27(11):1578-89. doi: 10.1016/j.joca.2019.06.011. Epub 2019 Jul 3.Kolasinski SL, Neogi T, Hochberg MC, et al. 2019 American college of rheumatology/arthritis foundation guideline for the management of osteoarthritis of the hand, hip, and knee. Arthritis Care Res (Hoboken). 2020 Feb;72(2):149-62. doi: 10.1002/acr.24131. Epub 2020 Jan 6.Kolasinski SL, Neogi T, Hochberg MC, et al. 2019 American college of rheumatology/arthritis foundation guideline for the management of osteoarthritis of the hand, hip, and knee. Arthritis Care Res (Hoboken). 2020 Feb;72(2):149-62. doi: 10.1002/acr.24131. Epub 2020 Jan 6.Fuggle N, Bere N, Bruycre O, et al. Management of hand osteoarthritis: from an US evidence based medicine guideline to a European patient centric approach. Aging Clin Exp Res. 2022 Sep;34(9):1985-95. doi: 10.1007/s40520-022-02176-y. Epub 2022 Jul 21.Fuggle N, Bere N, Bruycre O, et al. Management of hand osteoarthritis: from an US evidence based medicine guideline to a European patient centric approach. Aging Clin Exp Res. 2022 Sep;34(9):1985-95. doi: 10.1007/s40520-022-02176-y. Epub 2022 Jul 21.Bruyd'c O, Honvo G, Veronese N, et al. An updated algorithm recommendation for the management of knee osteoarthritis from the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO). Semin Arthritis Rheum. 2019 Dec;49(3): 337-50. doi: 10.1016/j.semarthrit.2019.04.008. Epub 2019 Apr 30.Bruyd'c O, Honvo G, Veronese N, et al. An updated algorithm recommendation for the management of knee osteoarthritis from the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO). Semin Arthritis Rheum. 2019 Dec;49(3): 337-50. doi: 10.1016/j.semarthrit.2019.04.008. Epub 2019 Apr 30.Verbruggen G, Goemaere S, Veys EM. Chondroitin sulfate: S/DMOAD (structure/ disease modifying anti-osteoarthritis drug) in the treatment of finger joint OA. Osteoarthritis Cartilage. 1998 May;6 Suppl A:37-8. doi: 10.1016/s1063-4584(98)80010-1.Verbruggen G, Goemaere S, Veys EM. Chondroitin sulfate: S/DMOAD (structure/ disease modifying anti-osteoarthritis drug) in the treatment of finger joint OA. Osteoarthritis Cartilage. 1998 May;6 Suppl A:37-8. doi: 10.1016/s1063-4584(98)80010-1.Gabay C, Medinger-Sadowski C, Gascon D, et al. Symptomatic effects of chondroitin 4 and chondroitin 6 sulfate on hand osteoarthritis: a randomized, double-blind, placebo-controlled clinical trial at a single center. Arthritis Rheum. 2011 Nov;63(11):3383-91. doi: 10.1002/art.30574Gabay C, Medinger-Sadowski C, Gascon D, et al. Symptomatic effects of chondroitin 4 and chondroitin 6 sulfate on hand osteoarthritis: a randomized, double-blind, placebo-controlled clinical trial at a single center. Arthritis Rheum. 2011 Nov;63(11):3383-91. doi: 10.1002/art.30574Лила АМ, Алексеева ЛИ, Таскина ЕА. Современные подходы к терапии остеоартрита с учетом обновленных международных рекомендаций. Русский медицинский журнал. Медицинское обозрение. 2019;3(11-2):48-52.Lila AM, Alekseeva LI, Taskina EA. Modern approaches to the treatment of osteoarthritis based on the updated international recommendations. Russkii meditsinskii zhurnal. Meditsinskoe obozrenie. 2019;3(11-2):48-52. (In Russ.).Veronese N, Demurtas J, Smith L, et al; European Geriatric Medicine Society Special Interest Groups in Systematic Reviews and Meta-Analyses and Arthritis. Glucosamine sulphate: an umbrella review of health outcomes. Ther Adv Musculoskelet Dis.2020 Dec 26;12:1759720X20975927. doi: 10.1177/1759720X20975927. eCollection 2020.Veronese N, Demurtas J, Smith L, et al; European Geriatric Medicine Society Special Interest Groups in Systematic Reviews and Meta-Analyses and Arthritis. Glucosamine sulphate: an umbrella review of health outcomes. Ther Adv Musculoskelet Dis.2020 Dec 26;12:1759720X20975927. doi: 10.1177/1759720X20975927. eCollection 2020.Tenti S, Giordano N, Mondanelli N, et al. A retrospective observational study of glucosamine sulfate in addition to conventional therapy in hand osteoarthritis patients compared to conventional treatment alone. Aging Clin Exp Res. 2020 Jun;32(6):1161-72. doi: 10.1007/s40520-019-01305-4. Epub 2019 Aug 19.Tenti S, Giordano N, Mondanelli N, et al. A retrospective observational study of glucosamine sulfate in addition to conventional therapy in hand osteoarthritis patients compared to conventional treatment alone. Aging Clin Exp Res. 2020 Jun;32(6):1161-72. doi: 10.1007/s40520-019-01305-4. Epub 2019 Aug 19.Kloppenburg M, Peterfy C, Haugen IK, et al. Phase IIa, placebo-controlled, randomised study of lutikizumab, an antiinterleukin-1 and anti-interleukin-1 dual variable domain immunoglobulin, in patients with erosive hand osteoarthritis. Ann Rheum Dis. 2019 Mar;78(3):413-20. doi: 10.1136/annrheum-dis-2018-213336. Epub 2018 Dec 14.Kloppenburg M, Peterfy C, Haugen IK, et al. Phase IIa, placebo-controlled, randomised study of lutikizumab, an antiinterleukin-1 and anti-interleukin-1 dual variable domain immunoglobulin, in patients with erosive hand osteoarthritis. Ann Rheum Dis. 2019 Mar;78(3):413-20. doi: 10.1136/annrheum-dis-2018-213336. Epub 2018 Dec 14.Kloppenburg M, Ramonda R, Bobacz K, et al. Etanercept in patients with inflammatory hand osteoarthritis (EHOA): a multicentre, randomised, double-blind, placebo-controlled trial. Ann Rheum Dis. 2018 Dec;77(12):1757-64. doi: 10.1136/annrheumdis-2018-213202. Epub 2018 Oct 3.Kloppenburg M, Ramonda R, Bobacz K, et al. Etanercept in patients with inflammatory hand osteoarthritis (EHOA): a multicentre, randomised, double-blind, placebo-controlled trial. Ann Rheum Dis. 2018 Dec;77(12):1757-64. doi: 10.1136/annrheumdis-2018-213202. Epub 2018 Oct 3.Schett G, Bainbridge C, Berkowitz M, et al. Anti-granulocyte-macrophage colonystimulating factor antibody otilimab in patients with hand osteoarthritis: a phase 2a randomised trial. Lancet Rheumatol. 2020;2: e623-e632.Schett G, Bainbridge C, Berkowitz M, et al. Anti-granulocyte-macrophage colonystimulating factor antibody otilimab in patients with hand osteoarthritis: a phase 2a randomised trial. Lancet Rheumatol. 2020;2: e623-e632.Aitken D, Laslett LL, Pan F, et al. A randomised doubleblind placebo-controlled crossover trial of HUMira (adalimumab) for erosive hand osteoarthritis - the HUMOR trial. Osteoarthritis Cartilage. 2018 Jul;26(7):880-7. doi: 10.1016/j.joca.2018.02.899. Epub 2018 Mar 2.Aitken D, Laslett LL, Pan F, et al. A randomised doubleblind placebo-controlled crossover trial of HUMira (adalimumab) for erosive hand osteoarthritis - the HUMOR trial. Osteoarthritis Cartilage. 2018 Jul;26(7):880-7. doi: 10.1016/j.joca.2018.02.899. Epub 2018 Mar 2.Chevalier X, Ravaud P, Maheu E, et al. Adalimumab in patients with hand osteoarthritis refractory to analgesics and NSAIDs: a randomised, multicentre, double-blind, placebo-controlled trial. Ann Rheum Dis. 2015 Sep;74(9):1697-705. doi: 10.1136/annrheum-dis-2014-205348. Epub 2014 May 9.Chevalier X, Ravaud P, Maheu E, et al. Adalimumab in patients with hand osteoarthritis refractory to analgesics and NSAIDs: a randomised, multicentre, double-blind, placebo-controlled trial. Ann Rheum Dis. 2015 Sep;74(9):1697-705. doi: 10.1136/annrheum-dis-2014-205348. Epub 2014 May 9.Richette P, Latourte A, Sellam J, et al. Efficacy of tocilizumab in patients with hand osteoarthritis: double blind, randomised, placebo-controlled, multicentre trial. Ann Rheum Dis. 2021 Mar;80(3):349-55. doi: 10.1136/annrheumdis-2020-218547. Epub 2020 Oct 14.Richette P, Latourte A, Sellam J, et al. Efficacy of tocilizumab in patients with hand osteoarthritis: double blind, randomised, placebo-controlled, multicentre trial. Ann Rheum Dis. 2021 Mar;80(3):349-55. doi: 10.1136/annrheumdis-2020-218547. Epub 2020 Oct 14.Kedor C, Detert J, Rau R, et al. Hydroxychloroquine in patients with inflammatory and erosive osteoarthritis of the hands: results of the OA-TREAT study-a randomised, double-blind, placebo-controlled, multicentre, investigator-initiated trial. RMD Open. 2021 Jul;7(2):e001660. doi: 10.1136/rmdopen-2021-001660.Kedor C, Detert J, Rau R, et al. Hydroxychloroquine in patients with inflammatory and erosive osteoarthritis of the hands: results of the OA-TREAT study-a randomised, double-blind, placebo-controlled, multicentre, investigator-initiated trial. RMD Open. 2021 Jul;7(2):e001660. doi: 10.1136/rmdopen-2021-001660.Kingsbury SR, Tharmanathan P, Keding A, et al. Hydroxychloroquine effectiveness in reducing symptoms of hand osteoarthritis: a randomized trial. Ann Intern Med. 2018 Mar 20;168(6):385-95. doi: 10.7326/M17-1430. Epub 2018 Feb 20.Kingsbury SR, Tharmanathan P, Keding A, et al. Hydroxychloroquine effectiveness in reducing symptoms of hand osteoarthritis: a randomized trial. Ann Intern Med. 2018 Mar 20;168(6):385-95. doi: 10.7326/M17-1430. Epub 2018 Feb 20.Lee W, Ruijgrok L, Boxma-de Klerk B, et al. Efficacy of hydroxychloroquine in hand osteoarthritis: a randomized, double-blind placebo-controlled trial. Arthritis Care Res (Hoboken). 2018 Sep;70(9):1320-5. doi: 10.1002/acr.23471. Epub 2018 Aug 12.Lee W, Ruijgrok L, Boxma-de Klerk B, et al. Efficacy of hydroxychloroquine in hand osteoarthritis: a randomized, double-blind placebo-controlled trial. Arthritis Care Res (Hoboken). 2018 Sep;70(9):1320-5. doi: 10.1002/acr.23471. Epub 2018 Aug 12.Davis CR, Ruediger CD, Dyer KA, et al. Colchicine is noteffective for reducing osteo-arthritic hand pain compared to placebo: a randomised, placebo-controlled trial (COLAH). Osteoarthritis Cartilage. 2021 Feb;29(2):208-14. doi: 10.1016/j.joca.2020.11.002. Epub 2020 Nov 21.Davis CR, Ruediger CD, Dyer KA, et al. Colchicine is noteffective for reducing osteo-arthritic hand pain compared to placebo: a randomised, placebo-controlled trial (COLAH). Osteoarthritis Cartilage. 2021 Feb;29(2):208-14. doi: 10.1016/j.joca.2020.11.002. Epub 2020 Nov 21.Ferrero S, Wittoek R, Allado E, et al. Methotrexate treatment in hand osteoarthritis refractory to usual treatments: a randomised, double-blind, placebo-controlled trial. Semin Arthritis Rheum. 2021 Aug;51(4):831-8. doi: 10.1016/j.semarthrit.2021.04.016. Epub 2021 May 6.Ferrero S, Wittoek R, Allado E, et al. Methotrexate treatment in hand osteoarthritis refractory to usual treatments: a randomised, double-blind, placebo-controlled trial. Semin Arthritis Rheum. 2021 Aug;51(4):831-8. doi: 10.1016/j.semarthrit.2021.04.016. Epub 2021 May 6.

The authors declare that there are no conflicts of interest present.